Research & Development

AI Tool DECIPHAER Unlocks TB Drug Mechanisms at Molecular Level
Research & Development AI Tool DECIPHAER Unlocks TB Drug Mechanisms at Molecular Level

What if the secret to conquering one of humanity’s deadliest foes lies hidden in the microscopic world of bacterial cells? Tuberculosis (TB), claiming millions of lives each year, continues to defy modern medicine with its grueling treatment demands and rising drug resistance. Yet, a revolutionary

How Is BiortusAI Revolutionizing Biopharma R&D with AI?
Research & Development How Is BiortusAI Revolutionizing Biopharma R&D with AI?

Imagine a landscape in biopharmaceutical research where the journey from concept to cure is no longer a decade-long slog but a streamlined sprint, driven by technology that predicts outcomes with startling accuracy. This vision is becoming reality with the launch of BiortusAI, an innovative

Cancer's Impact on Forensic Age Estimation Accuracy
Research & Development Cancer's Impact on Forensic Age Estimation Accuracy

Imagine a crime scene where a single drop of blood holds the key to identifying a suspect, not just by DNA but by estimating their age with remarkable precision, a technique that has become invaluable in modern investigations. Forensic age estimation tools, relying on DNA methylation patterns, have

How Rare Are Sellar Chondrosarcomas and How Are They Treated?
Research & Development How Rare Are Sellar Chondrosarcomas and How Are They Treated?

Welcome to an insightful conversation with Dr. Ivan Kairatov, a distinguished neurosurgeon renowned for his expertise in rare skull base tumors and innovative surgical techniques. With a focus on sellar chondrosarcomas—a particularly uncommon and challenging condition—Dr. Kairatov has been at the

Can a New RNAi Drug Revolutionize Hemophilia Treatment?
Research & Development Can a New RNAi Drug Revolutionize Hemophilia Treatment?

The realm of hemophilia treatment is witnessing a transformative wave, with innovative therapies challenging the status quo of managing this genetic blood clotting disorder, which has burdened patients for decades with frequent infusions to replace missing clotting factors. Now, a newly approved

How Does Genome Rewiring Drive Mantle Cell Lymphoma?
Research & Development How Does Genome Rewiring Drive Mantle Cell Lymphoma?

Mantle cell lymphoma (MCL), a rare yet aggressive form of blood cancer, affects approximately one in every 100,000 individuals annually, falling within the broader category of lymphoma, which ranks as the sixth most common cancer worldwide. Despite its relative rarity, the disease poses a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later